Sai Krishna Bhogadi, Qaidar Alizai, Christina Colosimo, Audrey L Spencer, Collin Stewart, Adam Nelson, Michael Ditillo, Lourdes Castanon, Louis J Magnotti, Bellal Joseph, Linda Dultz, George Black, Marc Campbell, Allison E Berndtson, Todd Costantini, Andrew Kerwin, David Skarupa, Sigrid Burruss, Lauren Delgado, Mario Gomez, Dalier R Mederos, Robert Winfield, Daniel Cullinane, Hamidreza Hosseinpour
BACKGROUND: Prognostic significance of different anticoagulants in TBI patients remains unanswered. We aimed to compare effects of different anticoagulants on outcomes of TBI patients. METHODS: A secondary analysis of AAST BIG MIT. Blunt TBI patients ≥50 years using anticoagulants presenting ICH were identified. Outcomes were progression of ICH and need for neurosurgical intervention (NSI). RESULTS: 393 patients were identified. Mean age was 74 and most common anticoagulant was aspirin (30%), followed by Plavix (28%), and coumadin (20%)...
June 3, 2023: American Journal of Surgery